OPGN: OpGen, Inc. Operating Profitability

The critical state of OpGen, Inc. (OPGN) business is driven by a lack of operational cash and the threat of bankruptcy. However, financial restructuring and the expansion of Acuitas tests in Europe create growth potential. Partnerships with hospitals for rapid infection diagnostics also support the company. The operating profit margin history on the GURU.Markets website demonstrates a support level where the 0.00 indicator determines the parameter status.
Summary analytical data breakdowns for OpGen, Inc. (OPGN)

As a portfolio manager, I evaluate this metric as the ratio of operating profit to revenue, which allows for the isolation of production efficiency from debt load and the tax regime. Analyzing the core business margin chart for OpGen, Inc. (OPGN), an investor will see how vulnerable the biopharmaceutical business's profitability is to raw material supply disruptions and regulatory costs associated with conducting international tests.